| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C Manzanedo, M A Aguilar, M Rodríguez-Arias, J Miñarr. Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behavioural brain research. vol 121. issue 1-2. 2001-06-28. PMID:11275296. |
the effects of dopamine (da) antagonists with different selectivity for the da receptors (sch 23390, 0.5, 0.25, 0.125 mg/kg; haloperidol, 0.2, 0.1 mg/kg; raclopride, 1.2, 0.6, 0.3 mg/kg; risperidone, 0.4, 0.2, 0.1 mg/kg; u-99194a maleate, 40, 20 mg/kg; clozapine, 2.5, 1.25, 0.625 mg/kg) on the acquisition of place conditioning and morphine-induced conditioned place preference (cpp) were explored in male mice. |
2001-06-28 |
2023-08-12 |
mouse |
| T Bast, W N Zhang, C Heidbreder, J Feldo. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience. vol 103. issue 2. 2001-06-14. PMID:11246148. |
while the hyperactivity is thought to depend on dopamine receptor activation in the nucleus accumbens, the dopamine d2-class receptor blocker haloperidol failed to antagonize the disruption of prepulse inhibition in previous studies. |
2001-06-14 |
2023-08-12 |
rat |
| T Bast, W N Zhang, C Heidbreder, J Feldo. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience. vol 103. issue 2. 2001-06-14. PMID:11246148. |
activation of accumbal dopamine receptors, which is blocked by clozapine and haloperidol to a comparable extent, seems to be crucial for the hyperactivity but not the disruption of prepulse inhibition. |
2001-06-14 |
2023-08-12 |
rat |
| M Schäfer, D Rujescu, I Giegling, A Guntermann, A Erfurth, B Bondy, H J Mölle. Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. The American journal of psychiatry. vol 158. issue 5. 2001-05-24. PMID:11329406. |
association of short-term response to haloperidol treatment with a polymorphism in the dopamine d(2) receptor gene. |
2001-05-24 |
2023-08-12 |
Not clear |
| D Walker, C Mahoney, V Ilivitsky, V J Knot. Effects of haloperidol pretreatment on the smoking-induced EEG/mood activation response profile. Neuropsychobiology. vol 43. issue 2. 2001-05-10. PMID:11174054. |
in a randomized, double-blind, repeated-measures design, quantitative electroencephalographic (eeg) changes and self-reports induced by the smoking of a single cigarette were assessed in 16 smokers following pretreatment with placebo and a dopamine antagonist, haloperidol (2 mg). |
2001-05-10 |
2023-08-12 |
human |
| M S Marty, J W Crissman, E W Carne. Evaluation of the male pubertal assay's ability to detect thyroid inhibitors and dopaminergic agents. Toxicological sciences : an official journal of the Society of Toxicology. vol 60. issue 1. 2001-05-10. PMID:11222874. |
weanling male cd rats (21 days old) were dosed for 30 d by gavage with vehicle (0.5% methocel) or the following eac classes (mg/kg/d): a potent thyroid agent (6-propylthiouracil, ptu, 240), a weak thyroid agent (phenobarbital, pb, 50 or 100), a dopamine antagonist (haloperidol, halo, 2 or 4), or a dopamine agonist (bromocryptine, brc, 10 or 50). |
2001-05-10 |
2023-08-12 |
rat |
| N Hussain, B A Flumerfelt, N Rajakuma. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience. vol 102. issue 2. 2001-05-03. PMID:11166125. |
acute administration of haloperidol induces the expression of the immediate-early gene c-fos in the striatum and nucleus accumbens via dopamine d(2) receptor antagonism. |
2001-05-03 |
2023-08-12 |
rat |
| N Hussain, B A Flumerfelt, N Rajakuma. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Neuroscience. vol 102. issue 2. 2001-05-03. PMID:11166125. |
the differential role that nmda receptors play in modulating haloperidol-mediated dopamine d(2) receptor antagonism between motor and associative areas of the striatum may contribute to the development of extrapyramidal symptoms following chronic haloperidol treatment. |
2001-05-03 |
2023-08-12 |
rat |
| K Sakai, X M Gao, T Hashimoto, C A Tamming. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse (New York, N.Y.). vol 39. issue 2. 2001-04-19. PMID:11180502. |
results show the expected dopamine d2 receptor upregulation in striatum predominantly with haloperidol, although mild d2 upregulation was apparent in striatum after olanzapine. |
2001-04-19 |
2023-08-12 |
human |
| I Bilic, I Zoricic, T Anic, J Separovic, D Stancic-Rokotov, D Mikus, G Buljat, D Ivankovic, G Aralica, I Prkacin, D Perovic, S Mise, I Rotkvic, M Petek, R Rucman, S Seiwerth, P Sikiri. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life sciences. vol 68. issue 16. 2001-04-19. PMID:11292068. |
the focus was on haloperidol (central dopamine antagonist)-stomach lesion, a longly described suitable counterpart of dopamine blocker cysteamine-duodenal lesion. |
2001-04-19 |
2023-08-12 |
mouse |
| I Bilic, I Zoricic, T Anic, J Separovic, D Stancic-Rokotov, D Mikus, G Buljat, D Ivankovic, G Aralica, I Prkacin, D Perovic, S Mise, I Rotkvic, M Petek, R Rucman, S Seiwerth, P Sikiri. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice. Life sciences. vol 68. issue 16. 2001-04-19. PMID:11292068. |
supporting central dopamine predominance for haloperidol stomach lesion induction, co-administration of peripheral dopamine receptor antagonist domperidone (5 mg/kg i.p.) |
2001-04-19 |
2023-08-12 |
mouse |
| A B Kosmachev, V D Tonkopiĭ, N P Podosinovikova, A O Zagrebin, E A Evdokimova, N M Libman, V V Petrov, V B Dolgo-Saburo. [Characteristics of effects of acetylene amino alcohols M-cholinoreceptor blockers on the dopaminergic system in Daphnia magna]. Eksperimental'naia i klinicheskaia farmakologiia. vol 63. issue 6. 2001-04-12. PMID:11202502. |
haloperidol and dimethpromide exhibit the properties of dopamine antagonists in the experiments on daphnia magna straus (crustaceae family). |
2001-04-12 |
2023-08-12 |
Not clear |
| C Videbaek, K Toska, L Friberg, S Holm, H R Angelo, G M Knudse. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. vol 21. issue 1. 2001-04-05. PMID:11149673. |
in vivo measurement of haloperidol affinity to dopamine d2/d3 receptors by [123i]ibzm and single photon emission computed tomography. |
2001-04-05 |
2023-08-12 |
human |
| C Videbaek, K Toska, L Friberg, S Holm, H R Angelo, G M Knudse. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. vol 21. issue 1. 2001-04-05. PMID:11149673. |
this study examines the feasibility of a steady-state bolus-integration method with the dopamine d2/d3 receptor single photon emission computer tomography (spect) tracer, [123i]ibzm, for determination of in vivo affinity of haloperidol. |
2001-04-05 |
2023-08-12 |
human |
| C Videbaek, K Toska, L Friberg, S Holm, H R Angelo, G M Knudse. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. vol 21. issue 1. 2001-04-05. PMID:11149673. |
in humans, kd for haloperidol binding was measured in four healthy volunteers that were examined twice: once with partial dopamine d2/d3 receptor blockade obtained by a scheduled infusion of unlabeled haloperidol (0.7 mg total dosage), and once in an unblocked state. |
2001-04-05 |
2023-08-12 |
human |
| S Kapur, P Roy, J Daskalakis, G Remington, R Zipursk. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. The American journal of psychiatry. vol 158. issue 2. 2001-03-08. PMID:11156818. |
increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. |
2001-03-08 |
2023-08-12 |
Not clear |
| S Kapur, P Roy, J Daskalakis, G Remington, R Zipursk. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. The American journal of psychiatry. vol 158. issue 2. 2001-03-08. PMID:11156818. |
the authors added haloperidol, a potent d(2) blocker, to ongoing treatment with clozapine in patients with schizophrenia to determine the effects of this combination on dopamine d(2) receptor blockade, prolactin level, and extrapyramidal side effects. |
2001-03-08 |
2023-08-12 |
Not clear |
| M H Joseph, S L Peters, P M Moran, G A Grigoryan, A M Young, J A Gra. Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience. vol 101. issue 4. 2001-03-01. PMID:11113341. |
bilateral local injections of the dopamine antagonist haloperidol into the nucleus accumbens (0.5 microg/side) before conditioning also potentiated latent inhibition. |
2001-03-01 |
2023-08-12 |
rat |
| V M Storozhuk, A V Sanzharovskii, V V Sachenko, B I Buse. Modulation of the spike activity of neocortex neurons during a conditioned reflex. Neuroscience and behavioral physiology. vol 30. issue 6. 2001-02-22. PMID:11127790. |
although dopamine, like glutamate, facilitated neuron spike activity during the period of application, the simultaneous facilitatory actions of glutamate and l-dopa were accompanied by occlusion of spike activity, and simultaneous application of glutamate and haloperidol suppressed spike activity associated with the conditioned reflex response. |
2001-02-22 |
2023-08-12 |
Not clear |
| D A Flockhart, Z Desta, S K Maha. Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions. Clinical pharmacokinetics. vol 39. issue 4. 2001-02-15. PMID:11069215. |
metoclopramide is a dopamine antagonist that may cause extrapyramidal effects when administered alone at high concentrations, or when coadministered with antipsychotic agents such as haloperidol or phenothiazines. |
2001-02-15 |
2023-08-12 |
Not clear |